Delivery Order SPE2DB20D1100-SPE2DB25FD0W6
Award Date
6/25/25
Potential Completion Date
7/17/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,504.62 firm-fixed-price contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,016.30 firm fixed price contract has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,016.30, is for the delivery of Tecentriq 840 mg/14 ml vials. It is a firm fixed-price delivery order contract with a completion date of December 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a medication, with a ceiling value of $17,009.24 and a period of performance through July 15, 2025. The contract is a firm fixed-price agreement and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a...
This is a $16,032.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product TECENTRIQ 840 MG/14 ML VIAL 14ML, with a final completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $86,205.24 and covers the delivery of Tecentriq 840 mg/14 ml vials. The contract was awarded on September 16, 2021, with an ultimate completion date of October 7, 2021. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, to provide the specialty medication Tecentriq (840 mg/14 ml vial) under a firm fixed price delivery order. The award has a ceiling value of $16,032.60 and a period of performance through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 840 mg/14 ml vials of the pharmaceutical product Tecentriq, with a potential value of $4,008.15 and a completion date of March 20, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this medication to support military treatment programs and...
This federal contract award, valued at $6,297.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567926066 - TECENTRIQ HYBREZA 1,875 MG 15ML, with a performance period extending to May 6, 2025. This is a delivery order contract with a firm fixed price pricing type. The award is not designated as a set-aside contract, indicating open competition....